Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a ...
BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...
SEATTLE, WA and IRVINE, CA / ACCESSWIRE / October 5, 2023 / Küleon LLC, a private biotechnology company that has built the industry's largest library of serotonergic drugs exhibiting G protein-biased ...
Shionogi & Co. Ltd. has synthesized spiroheterocycle derivatives acting as 5-HT2A and 5-HT2C receptor antagonists and/or inverse agonists reported to be useful for the treatment of neurodegeneration.
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant ...
2A Biosciences Inc. has divulged compounds acting as 5-HT2A and 5-HT2C receptor agonists reported to be useful for the treatment of atopic dermatitis, conjunctivitis, Crohn’s disease, type 2 diabetes, ...
Küleon LLC, a preclinical-stage biotechnology company building a best-in-class library of selective, G-protein-biased serotonergic medicines, today announced it has been awarded a $2 million grant ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Please provide your email address to receive an email when new articles are posted on . A clinical-stage biopharmaceutical company has announced positive topline data from a study evaluating a novel, ...
KB-128 is a “trifunctional” ligand that is a full 5-HT2C serotonin receptor agonist with little to no functional activity or agonism at the 5-HT2A/2B serotonin receptors. KB-128 also exhibits a ...